Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The Lord Mayor of Cork says he has few fears over jobs in the city’s booming pharmaceutical sector, despite threats from US ...

At its February monthly meeting, Chief Scientific Officer Dan ... the recent launch of the $700 million Lilly Institute for Genetic Medicine in Boston is just a recent example.

Heidi McWilliams, a 10-year Palm Beach resident, is chair of the organization's inaugural event at the Palm Beach County ...

Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, ...

Boston University President Melissa Gilliam visited Washington, D.C. Feb. 26 and spoke to an audience of around 150 BU alumni ...

According to Halozyme, the new version of Keytruda infringes on its patents, the report said. USAID cuts put tuberculosis response in peril, WHO says The Trump administration's decision to pause U.S.

Also at the summit, the ADDF will present Dr. Daniel Skovronsky, chief scientific officer for Lilly and president of Lilly Research Labs, with the organization's Melvin R. Goodes Prize for his ...

Read more from The Big Day, The Boston Globe’s new weddings column ... (She is currently a clinical research scientist at Eli Lilly; he consults for biotech companies in the area.) ...

A short course of androgen deprivation therapy (ADT) added to stereotactic body radiotherapy (SBRT) halved the risk of ...

AbbVie made a $350 million upfront payment to Gubra for rights to the drug, called GUB014295. Gubra is also eligible to receive another $1.9 billion if certain development and sales milestones are met ...